iTeos Therapeutics, Inc. (ITOS)
NASDAQ: ITOS · Real-Time Price · USD
6.67
-0.04 (-0.52%)
At close: May 9, 2025, 4:00 PM
6.73
+0.07 (0.98%)
After-hours: May 9, 2025, 7:34 PM EDT

iTeos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
2552813926951,6421,185
Upgrade
Market Cap Growth
-53.36%-28.39%-43.60%-57.70%38.57%-
Upgrade
Enterprise Value
-260-203-201-53745845
Upgrade
Last Close Price
6.677.6810.9519.5346.5633.82
Upgrade
PE Ratio
---7.197.66-
Upgrade
Forward PE
----10.82-
Upgrade
PS Ratio
8.068.0231.112.604.76-
Upgrade
PB Ratio
0.450.480.681.052.973.67
Upgrade
P/TBV Ratio
0.450.480.681.052.973.67
Upgrade
P/FCF Ratio
----3.21-
Upgrade
P/OCF Ratio
----3.20-
Upgrade
EV/Sales Ratio
----2.16-
Upgrade
EV/EBITDA Ratio
----3.04-
Upgrade
EV/EBIT Ratio
----3.04-
Upgrade
EV/FCF Ratio
----1.46-
Upgrade
Debt / Equity Ratio
0.010.010.010.010.01-
Upgrade
Debt / EBITDA Ratio
---0.040.02-
Upgrade
Debt / FCF Ratio
----0.01-
Upgrade
Asset Turnover
0.050.050.020.330.56-
Upgrade
Quick Ratio
13.7812.3513.4614.662.8322.45
Upgrade
Current Ratio
14.1312.6313.7614.962.8822.64
Upgrade
Return on Equity (ROE)
-23.68%-23.06%-18.19%15.90%48.98%-22.45%
Upgrade
Return on Assets (ROA)
-14.54%-14.47%-12.97%9.72%24.90%-14.97%
Upgrade
Return on Capital (ROIC)
-16.80%-16.66%-14.77%13.00%34.73%-16.58%
Upgrade
Return on Capital Employed (ROCE)
---17.90%42.20%-
Upgrade
Earnings Yield
-51.28%-47.91%-28.75%13.91%13.06%-3.21%
Upgrade
FCF Yield
-39.33%-35.57%-27.24%-16.14%31.17%-2.15%
Upgrade
Buyback Yield / Dilution
-18.24%-13.17%5.30%0.02%-150.49%-7336.28%
Upgrade
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q